Stenting Left Main - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Expansion or contraction of stenting in coronary artery disease?
New-onset atrial fibrillation after PCI and CABG for left main disease: insights from the EXCEL trial and additional studies
Left Main Revascularization in 2017 Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?
Left-main restenosis in the DES era-a call for action
Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial
Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention
Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease

|<< 1 2 3 4 5 6 7 ...>>|

Editorial

2019 Oct 12;394(10206):1299-1300.

JOURNAL：Lancet.

Article Link

Expansion or contraction of stenting in coronary artery disease?

Taggart DP, Pagano D.

7156

Keywords: PCI vs CABG; left main

ABSTRACT

In the past four decades, more than 20 trials of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) have tested whether iterative technical advances in PCI have made it as effective as CABG in patients with stable coronary artery disease. The clinical relevance of most of these trials to real-world practice has, however, been plagued by three issues.

First, by largely enrolling highly selected patients with low-severity coronary artery disease, the trials were inherently biased towards more favourable outcomes for PCI. Second, by limiting follow-up to a few years, the trials hid the accelerating divergence in survival benefit of CABG. Third, even in relatively contemporary trials, surgical patients received substantially inferior medical therapy, thereby mitigating the overall benefits of CABG.